OBSIDIAN THERAPEUTICS Trademark

Trademark Overview


On Tuesday, January 24, 2023, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 97765729. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Obsidian Therapeutics, Inc.. The OBSIDIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders
obsidian therapeutics

General Information


Serial Number97765729
Word MarkOBSIDIAN THERAPEUTICS
Filing DateTuesday, January 24, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "OBSIDIAN THERAPEUTICS" to the right of a seven-sided heptagon shape with lines within the heptagon that create three triangular elements surrounding a quadrilateral.
Goods and ServicesPharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Monday, February 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 27, 2023NEW APPLICATION ENTERED
Tuesday, February 14, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Wednesday, September 20, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 20, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, September 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 20, 2023EXAMINER'S AMENDMENT ENTERED
Friday, October 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 1 FILED
Thursday, June 27, 2024SOU EXTENSION 1 GRANTED